Results 81 to 90 of about 6,402,628 (197)

Development of Circumventricular Organs in the Mirror of Zebrafish Enhancer-Trap Transgenics

open access: yesFrontiers in Neuroanatomy, 2017
The circumventricular organs (CVOs) are small structures lining the cavities of brain ventricular system. They are associated with the semitransparent regions of the blood-brain barrier (BBB).
Marta García-Lecea   +11 more
doaj   +1 more source

Neurons in area postrema mediate vasopressin-induced enhancement of the baroreflex

open access: yes, 1990
Intravenous infusion of arginine vasopressin (AVP) has been shown to enhance baroreflex sensitivity, and this enhancement is dependent on the integrity of the area postrema.
V. S. Bishop, B. F. Cox, M. Hay
core   +1 more source

Glial Endozepines Inhibit Feeding-Related Autonomic Functions by Acting at the Brainstem Level

open access: yesFrontiers in Neuroscience, 2017
Endozepines are endogenous ligands for the benzodiazepine receptors and also target a still unidentified GPCR. The endozepine octadecaneuropeptide (ODN), an endoproteolytic processing product of the diazepam-binding inhibitor (DBI) was recently shown to ...
Florent Guillebaud   +11 more
doaj   +1 more source

GLP‐1 Receptor Agonists Post‐Bariatric Surgery (GRABS) Trial: Rationale, Design and Baseline Characteristics

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 9861-9870, November 2026.
ABSTRACT Aims No studies have investigated the synergistic effectiveness of Glucagon‐Like Peptide 1 Receptor Agonists (GLP1RAs) in patients with persistent obesity following bariatric surgery. The GLP‐1 Receptor Agonists Post‐Bariatric Surgery (GRABS) Trial aims to investigate the effectiveness of tirzepatide (TRZ) versus standard of care (SOC) after ...
J. M. Samuels   +12 more
wiley   +1 more source

Opioid Modulation of Major Neurotransmitter Systems: Acute, Chronic, and Withdrawal Effects

open access: yesEuropean Journal of Neuroscience, Volume 64, Issue 9, November 2026.
Opioids are widely used but also frequently misused drugs that affect multiple neurotransmitter systems, including dopaminergic, glutamatergic, GABAergic, serotonergic, and cholinergic pathways. Opioid‐induced neuroadaptations depend on the duration of drug exposure, with distinct changes also emerging following drug discontinuation.
Daniela Novakova   +2 more
wiley   +1 more source

Area Postrema: A Unique Regulator of Cardiovascular Function

open access: yes, 1992
The area postrema, which does not have a blood-brain barrier, can sense changes in levels of blood-borne hormones. This circumventricular organ plays an important role in animal models of hypertension, recovery from hemorrhage, control of baroreflexes ...
KL Barnes   +3 more
core   +1 more source

Proportion and Clinical Characteristics of Double‐Seronegative NMOSD in a Multicenter Real‐World Cohort

open access: yesEuropean Journal of Neurology, Volume 33, Issue 11, November 2026.
ABSTRACT Background Recent 2025 neuromyelitis optica spectrum disorder (NMOSD) criteria distinguish AQP4‐IgG‐positive disease from seronegative‐syndromic groups, into which double‐seronegative‐NMOSD (DN‐NMOSD) may be reclassified, suggesting the need to better characterize DN‐NMOSD within prior diagnostic frameworks.
Jae‐Won Hyun   +8 more
wiley   +1 more source

Area Postrema Syndrome [PDF]

open access: yesThe Neurohospitalist, 2018
Carlos R, Camara-Lemarroy   +5 more
openaire   +2 more sources

GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms

open access: yesObesity Reviews, Volume 27, Issue 11, November 2026.
ABSTRACT GLP‐1 receptor agonist medications have the potential to promote marked weight loss, but maximal and sustained benefit may be compromised by poor compliance and cessation of use. Development of next‐generation medications that address current obstacles to effective use and development of effective adjunct treatments will benefit from better ...
Giorgia Rutigliani   +8 more
wiley   +1 more source

Chemotherapy‐Induced Nausea and Vomiting in Early Breast Cancer Patients Receiving Adjuvant Chemotherapy With Fluorouracil, Epirubicin, Cyclophosphamide Followed by Docetaxel Versus an Anthracycline‐Free Regimen With Docetaxel, Cyclophosphamide—Results From a Randomized Clinical Trial

open access: yesInternational Journal of Cancer, Volume 159, Issue 8, Page 1990-2003, 15 October 2026.
Chemotherapy‐induced nausea and vomiting (CINV) remains a significant clinical problem despite modern antiemetics. In particular, antiemetic strategies for emerging cancer therapies lack detailed evaluation. This randomized trial analyzed hourly CINV data for patients with early breast cancer who received either docetaxel plus cyclophosphamide (TC) or ...
Manuel Hörner   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy